Curaleaf Holdings, Inc. filed a current report on November 5, 2026, disclosing that on November 3, 2026, the company issued a statement regarding an alternative proposal for Aurora Cannabis.

Key Highlights

  • Statement issued: Curaleaf issued a statement on November 3, 2026, addressing an alternative proposal for Aurora Cannabis.
  • Filing type: The current report was filed under Item 8.01 (Other Events) and also checked as a written communication pursuant to Rule 425 under the Securities Act.
  • No securities registered on an exchange: According to the filing, securities registered pursuant to Section 12(b) of the Act are listed as "None."
  • Registrant details: Curaleaf Holdings, Inc. is incorporated in British Columbia, Canada, with principal executive offices at 250 Harbor Drive, Third Floor, Stamford, Connecticut 06902.
  • Signed by: The report was signed by Peter Clateman, Chief Legal Officer of Curaleaf Holdings, Inc., on November 3, 2026.

Curaleaf's November 2026 Statement on Aurora Cannabis Alternative Proposal

According to the filing, Curaleaf Holdings, Inc. issued a statement on November 3, 2026, concerning what the registrant described as "the alternative proposal for Aurora Cannabis." The full text of that statement was attached to the current report as Exhibit 99.1, identified in the filing as a press release dated November 3, 2026. The filing does not reproduce the substance of the statement within the body of the report itself.

The report was filed under Item 8.01 (Other Events) and was simultaneously checked as a written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425). Curaleaf Holdings, Inc. is incorporated under the laws of British Columbia, Canada, and maintains its principal executive offices in Stamford, Connecticut. The company's Commission File Number is 333-249081 and its I.R.S. Employer Identification Number is 98-1461045, as stated on the cover page of the filing.

The filing expressly states that the information contained in the current report, including Exhibit 99.1, "shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended." The report carries no registered exchange-listed securities under Section 12(b) of the Act, according to the cover page disclosure. The report was authorized and signed by Peter Clateman in his capacity as Chief Legal Officer of Curaleaf Holdings, Inc.

What Was Disclosed

Curaleaf Holdings, Inc. filed a current report disclosing that it issued a statement on November 3, 2026, regarding an alternative proposal for Aurora Cannabis. The press release containing that statement was attached as Exhibit 99.1 to the filing.